Romilast is the only medicine of its kind for COPD and works differently from steroids. It belongs to a group of medications called PDE4 (phosphodiesterase-4) inhibitors. Romilast is a prescription medicine used in adults with severe COPD to decrease the number of flare-ups or the worsening of COPD symptoms (exacerbations). Romilast is not a bronchodilator and should not be used for treating sudden breathing problems. If you have severe COPD, flare-ups are not completely avoidable, but you may be able to decrease how often you have them. With Romilast, you may be able to help protect yourself from the risk of future flare-ups.
3. SEVERE COPD &
COPD SYMPTOMS
Chronic Obstructive Pulmonary
Disease (COPD) is a lung disease
that makes it hard to empty air out
of the lungs, so it's hard to breathe.
Many people with COPD can have
chronic bronchitis and your doctor
will figure out if you have this type
of COPD. Your doctor will also tell
you the severity of your COPD,
which may be mild, moderate, or
severe.
Coping with COPD can be tough,
especially when it is severe. As COPD
gets worse, COPD symptoms usually
become more severe. COPD symptoms
that may occur include:
ONGOING
COUGH
SHORTNESS OF BREATH
WHILE DOING ACTIVITIES
EXCESS MUCUS
PRODUCTION
WHEEZING
4. COPD FLARE-UPS
What are flare-ups?
Flare-ups are those times when your
usual breathing problems become
noticeably worse.
• Different things can make a flare-up
happen. The most common causes of a
flare-up are an infection in your lungs
and outdoor pollution.
• In some cases, the cause of the flare-
up is unknown. If you feel your COPD
symptoms getting worse, you
shouldn't ignore them. Flare-ups can
be serious and may last for days or
weeks.
• Once you’ve had a flare-up, you are
more likely to have another one. So it's
important that you try to reduce the
number of flare-ups you experience.
5. COPD FLARE-UPS
What are flare-ups?
Flare-ups are those times when your
usual breathing problems become
noticeably worse.
• Different things can make a flare-up
happen. The most common causes of a
flare-up are an infection in your lungs
and outdoor pollution.
• In some cases, the cause of the flare-
up is unknown. If you feel your COPD
symptoms getting worse, you
shouldn't ignore them. Flare-ups can
be serious and may last for days or
weeks.
• Once you’ve had a flare-up, you are
more likely to have another one. So it's
important that you try to reduce the
number of flare-ups you experience.
Warning signs of a COPD flare-up may include:
INCREASED
COUGHING
WORSENING
SHORTNESS OF BREATH
INCREASE IN
AMOUNT OF MUCUS
WHEEZING
CHEST
TIGHTNESS
6. WHY ®(Roflumilast) Tablets?
• Romilast is the only medicine of its kind for COPD and works
differently from steroids. It belongs to a group of medications called
PDE4 (phosphodiesterase-4) inhibitors.
• Romilast is a prescription medicine used in adults with severe
COPD to decrease the number of flare-ups or the worsening of COPD
symptoms (exacerbations).
• Romilast is not a bronchodilator and should not be used for treating
sudden breathing problems.
7. WHY ®(Roflumilast) Tablets?
• If you have severe COPD, flare-ups are not completely avoidable, but
you may be able to decrease how often you have them. With
Romilast, you may be able to help protect yourself from the risk of
future flare-ups.
9. Clinical Evidence
Romilast REDUCES THE RATE OF EXACERBATIONS VERSUS PLACEBO
PLACEBO +
BRONCHODILATORS
ROFLUMILAST +
BRONCHODILATORS
Romilast ENHANCES
EXACERBATIONS PROTECTION
10. Clinical Evidence
Romilast SIGNIFICANTLY INCREASES IN FEV1
PLACEBO +
BRONCHODILATORS
ROFLUMILAST +
BRONCHODILATORS
Romilast ENSURES
BREATHING COMFORT
CHANGE FROM
BASELINE IN PRE-
BRONCHODILATOR
FEV1 OVER 12
MONTHS
11. At a Glance
• Romilast is a PDE4 (phosphodiesterase-4) inhibitor used to treat
COPD.
• Romilast -the first and only medicine of its kind for COPD and
works differently from steroids
• Romilast reduces rate of exacerbations and improves lung
function.
• Romilast is recommended by Gold Guideline(Global Initiative
for Chronic Obstructive Lung Diseases) for COPD treatment
• Romilast is US FDA and European Union Approved COPD
treatment option